ContraFect Announces Pricing of Its Initial Public Offering
July 29, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Jul 29, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
Journal of Infectious Diseases Publishes ContraFect Corporation's Scientific Research
May 13, 2014 08:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 13, 2014) - ContraFect Corporation, a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening,...
ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors
April 24, 2014 08:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Apr 24, 2014) - ContraFect Corporation, a leader in the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant...
ContraFect Announces Management Team Changes
November 21, 2013 15:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Nov 21, 2013) - ContraFect Corporation announced that Ms. Julia P. Gregory was appointed interim Chief Executive Officer, succeeding Dr. Robert Nowinski, the...
ContraFect Corporation to Present at 12th Annual BIO Investor Forum
October 01, 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Oct 1, 2013) - ContraFect Corporation announced that Dr. Robert Nowinski, the company's founder and chief executive officer, and Julia P. Gregory, the company's...
ContraFect to Present at the 2013 Stifel Healthcare Conference
September 05, 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 5, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert C. Nowinski, the Company's...
ContraFect Completes $11.8 Million Financing
September 04, 2013 10:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that it has successfully closed a...
ContraFect Corporation Showcases CF-301 at ICAAC 2013 Meeting in Denver, CO
August 22, 2013 09:57 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 22, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that ContraFect has been selected to...
ContraFect to Present at the 5th Annual Biotech Showcase
January 04, 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Jan 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert Nowinski, the Company's founder...
ContraFect to Present at the 11th Annual BIO Investor Forum
October 03, 2012 09:12 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwire - Oct 3, 2012) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Julia P. Gregory, the Company's executive...